CVC Capital, Goldman Sachs Alternatives and Kensington Capital Partners are among the PE firms investing in respiratory care.
4 min read · 19 September 2025
'The fundamentals of the industry are driven by demographics, and broadening the scope provides a bit of growth opportunity,' says Kensington's Tom Kennedy.
3 min read · 16 September 2025
An increasing number of patients are seeking care in outpatient settings such as ambulatory surgery centers over hospitals due to their affordability and shorter wait times. A round-up of these deals from the last six months. Also: a look at a dual acquisition by Accord Asset Partners and Paras Capital Partners in a physical therapy provider network.
3 min read · 12 September 2025
Great Hill Partners, Olympus Partners and Wellspring Capital Management are among the PE firms investing in ambulatory surgical care.
2 min read · 12 September 2025
A dive into deals in the physical medicine and rehabilitation sector and explore what PM&R is about; a look at a healthcare IT acquisition by Bain Capital within the payer sector and its merger with another of the firm’s portcos, and a similar healthcare IT investment this week by Goldman Sachs and Avista Healthcare Partners.
4 min read · 05 September 2025
Great Point Partners, Hildred Capital Partners and OMERS Private Equity are among the PE firms investing in PM&R care.
4 min read · 05 September 2025
A round-up seven patient engagement tech transactions from the last six months; a look at a merger between Water Street Healthcare Partners-backed Eversana and Waltz Health to create a new pharma commercialization and patient access platform; recommedations from PE Hub’s editorial team on books, podcasts and museum exhibits that you can enjoy as we head into autumn.
5 min read · 29 August 2025
Bain Capital, Blackstone, KKR and Advent International are among the PE firms buying or selling patient engagement technology assets.
4 min read · 29 August 2025
'The optimism around stability is probably higher than I've heard it has been at any other time in the last couple of years,' said Bain & Co's Nirad Jain as the firm releases new healthcare PE report.
8 min read · 28 August 2025
'Historically, everything required an operation,' said Lee Equity's Mark Gormley. 'Now, the new drugs and treatments are a lot more specific and sensitive.'
3 min read · 27 August 2025